Obituary – Songya Pang, MD To the Pediatric Endocrine Community: It is with great sadness that we acknowledge the…
Read MoreMore Articles
Dear PES Members, Wow! Those of you who attended know that we just finished a remarkably successful Annual Meeting. Attendance set a new record—1223 compared to 1097 in Chicago and…
Read More
Dalhila Solorzano Rubio, MD I am currently a second-year pediatric endocrinology fellow at the University of Utah. My journey began in Colombia, where I obtained my medical degree and worked…
Read More
Maria Iandolo New, MD (December 11, 1928 to July 26, 2024) Submitted by Alan D. Rogol, MD, Ph.D. Dr New was a pioneering pediatric endocrinologist and Pediatrics Chair at Cornell…
Read More
PES Statement Supporting Access to Gender Care The Pediatric Endocrine Society supports a patient and family/caregiver-centered approach to healthcare for all the conditions we treat. Our goal is provision of…
Read More
Dear PES Members, Although the times are turbulent, it is important to recognize that we at PES have a lot to celebrate. Several things come to mind immediately: -Our Annual…
Read More
Khushboo Golani, MD My name is Khushboo Golani, and I am currently a second-year fellow at Texas Children’s Hospital, Baylor College of Medicine in Houston, Texas. My medical journey began…
Read More
Joseph Karpel, PA-C, MPH, BCADM I am a graduate of the Touro University California MPH/MSPAS Program. During my clinical year, I completed a three-month rotation with the Diabetes Research Education…
Read More
Henry R. Harrower, MD (April 30, 1883-January 2, 1953) Organotherapist submitted by Alan Rogol Henry Harrower, an entrepreneurial organotherapist, organized the founding of the Association for the Study of Internal…
Read More
New Drugs and Therapeutics Update: INVOKANA® (canagliflozin) Prepared by Preneet Cheema Brar, MD, MS and Daniel Mak, MD. INVOKANA® (canagliflozin) In December 2024, the FDA approved INVOKANA® (canagliflozin) for…
Read More
New Drugs and Therapeutics Update: VYKAT™ XR (diazoxide choline) Prepared on behalf of PES Drugs and Therapeutics Committee by Dania Al-Hamad, MD, and Neha Patel, DO. On March 26, 2025,…
Read More